Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer - Concepedia

Concepedia

Publication | Open Access

Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer

DOI Full Paper Access

95

Citations

30

References

2015

Year

Di Cui, Jinlu Dai, Jill M. Keller, Atsushi Mizokami, Shujie Xia, Evan T. Keller

Clinical Cancer Research

Abstract

These results reveal that PF-03084014 enhances docetaxel-mediated tumor response and provides a rationale to explore GSIs as adjunct therapy in conjunction with docetaxel for men with CRPC.

References

	Year	Citations

Page 1